N1-MethylpseudoUridine-5'-Triphosphate

N1-MethylpseudoUridine-5'-Triphosphate
Product Description

N1-MethylpseudoUridine-5'-Triphosphate is a modified NTP for incorporation into messenger RNAs (mRNA) using T7 RNA Polymerase. Incorporation of N1-methylpseudouridine can reduce the immunogenicity of the resulting mRNA. The sodium form N1-MethylpseudoUridine-5'-Triphosphate Sodium (B2706-358101) is in stock.

Read more Show less

BOC Sciences

  • US
  • 2022
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Laboratory Services
Supply Chain
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    1428903-59-6
  • Details
    Purity: ≥95%Appearance: Clear colourless solution
    Synonyms: 1-Methylpseudouridine-5'-Triphosphate; N1-Methylpseudo-UTP; 2,4(1H,3H)-Pyrimidinedione, 5-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-1-methyl-; 1-Methylpseudo-UTP


    IUPAC Name: [[(2R,3S,4R,5S)-3,4-dihydroxy-5-(1-methyl-2,4-dioxopyrimidin-5-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

    Storage: Storage at -20°C
  • Measured In
    gram
More specifications Fewer specifications
Sales Markets
Show more Show less

BOC Sciences

  • US
  • 2022
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Laboratory Services
Supply Chain
View company profile

More Products from BOC Sciences (1)

  • Polyquaternium 1

    Product Polyquaternium 1

    Polyquaternium 1 is an ophthalmic preservative.

BOC Sciences resources (2)

  • BOC Sciences Reports Strong Capabilities of CDMO Operations

    News BOC Sciences Reports Strong Capabilities of CDMO Operations

    BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.

    11 May 2023
  • Webinar: Naturally Occurring Sensitive Nucleic Acids, Applications and Chemical Synthesis

    Webinar Webinar: Naturally Occurring Sensitive Nucleic Acids, Applications and Chemical Synthesis

    In this presentation, Dr. Shiyue Fang will showcase experimental examples of sensitive nucleosides, including their biological roles and relationships to clinical applications, challenges related to nucleic acids synthesis containing sensitive nucleosides, and the current status of the Dim-Dmoc method developed by his research group at the Michigan Technological University that overcomes related obstacles. In addition, Dr. Fang will also share personal opinions regarding the potential applications of sensitive nucleic acids accessible by the Dim-Dmoc method.
    Resource from https://www.bocsci.com/webinar-naturally-occurring-sensitive-nucleic-acids-applications-and-chemical-synthesis.html.
    2023-06-13